Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database Analysis

Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database Analysis

Courtney Johnson,1 Jennifer Stephens,1 Christopher Walker,2 Joseph C Cappelleri,3 Ahmed Shelbaya4 1Pharmerit International, Real World Evidence and Data Analytics, Bethesda, MD, USA; 2Pfizer Ltd., Global Medical Affairs, Tadworth, Surrey, England; 3Pfizer Inc., Statistics, Groton, CT, USA; 4Pfiz...

Full description

Bibliographic Details
Main Authors: Johnson C, Stephens J, Walker C, Cappelleri JC, Shelbaya A
Format: Article
Language:English
Published: Dove Medical Press 2020-01-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
generic
healthcare resource use
celebrex
nsaids
switching
discontinuation
Online Access:https://www.dovepress.com/economic-outcomes-related-to-persistence-and-dosing-of-celecoxib-in-pa-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/economic-outcomes-related-to-persistence-and-dosing-of-celecoxib-in-pa-peer-reviewed-article-CEOR

Similar Items